Switch to:
More From Other Websites
THERAVANCE INC Files SEC form 8-K, Change in Directors or Principal Officers Sep 19 2014
THERAVANCE INC Files SEC form 8-K, Regulation FD Disclosure Sep 18 2014
THERAVANCE INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Sep 08 2014
THERAVANCE INC Files SEC form 8-K, Other Events Sep 04 2014
Drug M&A Boom Driven By Long-Term Trends: PwC Sep 03 2014
THERAVANCE INC Files SEC form 8-K, Regulation FD Disclosure Sep 02 2014
Strong On High Relative Volume: Theravance (THRX) Aug 26 2014
Why the Baupost Group starts new position in Theravance Biopharma Aug 25 2014
THERAVANCE INC Files SEC form 8-K, Change in Directors or Principal Officers Aug 22 2014
Theravance to Present at the Baird 2014 Health Care Conference Aug 21 2014
THERAVANCE INC Financials Aug 15 2014
Theravance (THRX) Incurs Narrower-than-Expected Loss in Q2 Aug 08 2014
THERAVANCE INC Files SEC form 10-Q, Quarterly Report Aug 07 2014
THERAVANCE INC Files SEC form 8-K, Results of Operations and Financial Condition Aug 06 2014
Theravance Reports Second Quarter 2014 Financial Results Aug 06 2014
Theravance, Inc. Appoints Michael W. Aguiar as President and Chief Executive Officer Aug 06 2014
Q2 2014 THERAVANCE INC Earnings Release - After Market Close Aug 06 2014
Theravance to Report Second Quarter 2014 Financial Results on August 6, 2014 Jul 29 2014
[$$] At Theravance, It's Hard to Breathe Easy Jul 25 2014
Theravance (THRX) Is in Oversold Territory: What's Next? Jul 25 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK